PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-477 Cr | ₹-434 Cr | ₹-1,339 Cr | ₹-1,812 Cr | ₹-4,480 Cr |
What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-477 Cr |
| Mar2024 | ₹-434 Cr |
| Mar2023 | ₹-1,339 Cr |
| Mar2022 | ₹-1,812 Cr |
| Mar2021 | ₹-4,480 Cr |
How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-477 Cr | Negative | |
| Mar2024 | ₹-434 Cr | Negative | |
| Mar2023 | ₹-1,339 Cr | Negative | |
| Mar2022 | ₹-1,812 Cr | Negative | |
| Mar2021 | ₹-4,480 Cr | - | |
Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,254.4 Cr | -4.9% | 17.8% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.9% |
17.8% |
-17.7% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses